As of May 29
| +0.07 / +0.05%|
The 18 analysts offering 12-month price forecasts for Edwards Lifesciences Corp have a median target of 150.00, with a high estimate of 170.00 and a low estimate of 127.00. The median estimate represents a +14.75% increase from the last price of 130.72.
The current consensus among 22 polled investment analysts is to Buy stock in Edwards Lifesciences Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.